首页> 外文期刊>Analytical methods >Diatomaceous earth supported liquid extraction and LC-MS/MS determination of elvitegravir and ritonavir in rat plasma: application to a pharmacokinetic study
【24h】

Diatomaceous earth supported liquid extraction and LC-MS/MS determination of elvitegravir and ritonavir in rat plasma: application to a pharmacokinetic study

机译:硅藻土支持的液体萃取和大鼠血浆中艾维格韦和利托那韦的LC-MS / MS测定:在药代动力学研究中的应用

获取原文
           

摘要

A rapid, sensitive and selective bio-analytical method was developed for determination of elvitegravir and ritonavir in rat plasma by high-performance liquid chromatographya€“tandem mass spectrometry. Sample preparation was based on diatomaceous earth supported liquid extraction using dichloromethane to extract elvitegravir and ritonavir from rat plasma. Chromatographic separation was performed on a Waters Symmetry C18 column (4.6 ?— 250 mm, 5 ??m) using 20 mM ammonium formate containing 0.05% trifluoroacetic acid and acetonitrile (35:65 v/v) for isocratic elution and mass detection. Calibration curves were linear with regression coefficients greater than 0.997 over the concentration range of 2a€“5000 ng mLa?’1 for elvitegravir and ritonavir. Absolute mean recoveries were in the range of 87.31 to 92.18% and no significant interferences were observed at the retention times of the elvitegravir, ritonavir and internal standard. The method exhibited good intra- and inter-day performance in terms of 1.55a€“7.47% precision and 0a€“5% accuracy. The developed method has been successfully applied to the pharmacokinetic study of elvitegravir in healthy rats following a single oral administration of a 15 mg kga?’1 dose boosted with 5 mg kga?’1 ritonavir.
机译:建立了一种快速,灵敏,选择性的生物分析方法,采用高效液相色谱-串联质谱法测定大鼠血浆中的依维戈韦和利托那韦。样品制备基于硅藻土支持的液体萃取,使用二氯甲烷从大鼠血浆中萃取出elvitegravir和ritonavir。在Waters Symmetry C18色谱柱(4.6?-250 mm,5?m)上进行色谱分离,使用20 mM的含有0.05%三氟乙酸和乙腈(35:65 v / v)的甲酸铵进行等度洗脱和质量检测。校正曲线是线性的,在elvitegravir和ritonavir的浓度范围为2a€5000 ng mLa?-1时回归系数大于0.997。绝对平均回收率在87.31至92.18%的范围内,在elvitegravir,ritonavir和内标物的保留时间未观察到明显的干扰。该方法在1.55a“ 7.47%的精度和0a” 5%的精度方面表现出良好的日内和日间性能。单次口服15 mg kga -1剂量的5 mg kga -1利托那韦增强剂量后,该开发的方法已成功应用于健康大鼠的elvitegravir药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号